Several distinct mechanisms contributing to inhibit glucocorticoid activity in SLE patients have been identified, and overexpressed P-gp in peripheral lymphocytes was demonstrated to be one of these mechanisms (5,16–20). The gene discussed is PGP; the disease is systemic lupus erythematosus.